Vetoquinol Shares Jump on 22% First-Half Profit Increase

By EC Assets · Published 11 September 2026

Vetoquinol shares surged significantly following the French animal health group's report of a 22% increase in first-half net income. The company also demonstrated strong cash flow generation during the period. This performance marks a return to growth for Vetoquinol in the first half of fiscal 2026. Vetoquinol's net income reached €30.5 million in the first half of 2026. This figure represents 11.8% of total sales for the period. The company's sales rose 3.4% at constant exchange rates to €259.3 million. MarketScreener reported revenue of €259m. Cash flow generation totaled €59 million. The growth was driven by strong performance in the U.S. market. Sales in the U.S. market increased by 13.1% in the first half. The company's results were achieved in an uncertain international environment. This article is intended for informational purposes only. It does not constitute investment advice.